Mozambique, where malaria is nationally endemic and still a major driver of mortality especially among children, is a good example of how collaboration between government, civil society and the private sector can contribute to an effective response to the disease.
Two principal recipients of malaria grants in Nigeria have been implicated in fraud and financial irregularities, following an investigation by the Office of the Inspector General (OIG), and have committed to returning some $350,000 to the Fund.
Catholic Relief Services, the principal recipient (PR) of Global Fund grants for malaria management in Niger, will expand its slate of services responding to the malaria epidemic, with testing and first-line medication.
The Global Fund Secretariat will lift the suspensions of two major suppliers of long-lasting impregnated nets (LLINs) who were found to have paid kickbacks to government officials in Cambodia.
Acting on the recommendations of the Sanctions Panel, the Secretariat also imposed three conditions on Vestergaard Frandsen and Sumitomo Chemical Co in order to remain eligible to compete in tenders for future commodity purchases.
OIG Investigation in Cambodia Prompts Suspension of Two Top LLIN Suppliers Over $410,712 in Kickbacks
Two suppliers responsible for nearly 50% of all long-lasting insecticide-treated nets (LLINs) purchased by the Global Fund on behalf of malaria projects worldwide have been suspended following an investigation in Cambodia into widespread fraud and kickbacks paid to government officials.
Of the approximately 80 million insecticide-treated nets distributed through Global Fund–supported programmes in 2012, about 66 million (73%) went to sub-Saharan African countries. This is well below half the 150 million insecticide-treated nets that the World Health Organisation estimates are needed annually to protect all populations at risk of malaria in this region.
The Global Fund announced this month that a cumulative total of 1.75 million people living with HIV have been reached with antiretroviral (ARV) treatment through AIDS programs it supports, a 59 per cent increase over the totals as of a year ago.